Literature DB >> 29650556

Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong.

Kwok-Chiu Chang1, Eric Chung-Ching Leung2, Wing-Sze Law2, Wai-Man Leung2, Lai-Bun Tai2, Shuk-Nor Lee2, Fai-Man Lam3, Chi-Hung Chau3, Thomas Yun-Wing Mok4, Wing-Wai Yew5, Chi-Chiu Leung2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29650556     DOI： 10.1183/13993003.00159-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

Review 1.  New Drugs for the Treatment of Tuberculosis.

Authors:  Elisa H Ignatius; Kelly E Dooley
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 4.967

Review 2.  Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging.

Authors:  Yang Li; Feng Sun; Wenhong Zhang
Journal:  Drug Dev Res       Date:  2018-12-11       Impact factor: 4.360
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.